Neuphoria Therapeutics (NEUP) Goodwill & Intangibles (2020 - 2026)

Neuphoria Therapeutics (NEUP) has 7 years of Goodwill & Intangibles data on file, last reported at $13.2 million in Q1 2026.

• Quarterly Goodwill & Intangibles fell 2.01% year-over-year to $13.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.2 million (down 2.01% YoY) and the FY2025 annual result came in at $13.4 million, down 5.04% from the prior year.
• Goodwill & Intangibles held at $13.2 million in Q1 2026 per NEUP's latest filing, from $13.2 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $16.3 million in Q2 2022 and bottomed at $13.2 million in Q1 2026.
• The 5-year median for Goodwill & Intangibles is $14.2 million (2024), against an average of $14.1 million.
• The widest annual swing landed in 2022, when Goodwill & Intangibles surged 108.74%; it then declined 8.41% in 2023.
• Tracing NEUP's Goodwill & Intangibles over 5 years: stood at $16.3 million in 2022, then slipped by 9.99% to $14.6 million in 2023, then declined by 7.48% to $13.5 million in 2024, then declined by 2.45% to $13.2 million in 2025, then retreated by 0.45% to $13.2 million in 2026.
• Per Business Quant, the three latest NEUP Goodwill & Intangibles figures stand at $13.2 million (Q1 2026), $13.2 million (Q4 2025), and $13.3 million (Q3 2025).

Peer Comparison